ExploreWatchlistsPricing
  1. JP-listed companies
  2. PeptiDream Inc.
  3. Financials
  4. Return on Assets

PeptiDream Inc. (4587)

Market cap
¥153.7B
P/E ratio
Peptidream develops new drugs using its proprietary PDPS platform and creates radiopharmaceuticals for diagnosing and treating cancer and other diseases.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Dec 31, 2025-4.4-123.88%
Dec 31, 202418.5+306.81%
Dec 31, 20234.6-72.62%
Dec 31, 202216.6+22.57%
Dec 31, 202113.6-29.60%
Dec 31, 202019.3-775.79%
Dec 31, 2019-2.8-118.80%
Jun 30, 201915.2-2.19%
Jun 30, 201815.5+4.87%
Jun 30, 201714.8-7.97%
Jun 30, 201616.1+9.85%
Jun 30, 201514.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat